A novel mutation (p.Y24N) in NHP2 leads to idiopathic pulmonary fibrosis and lung carcinoma chronic obstructive lung disease by disrupting the expression and nucleocytoplasmic localization of NHP2

Lv Liu,Yue Sheng,Chen-Yu Wang,Xiao Liu,Ting Guo,Hong Peng,Hong Luo,Liang-Liang Fan
DOI: https://doi.org/10.1016/j.bbadis.2023.166692
IF: 6.633
2023-06-01
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Abstract:• Idiopathic pulmonary fibrosis (IPF) is a kind of chronic interstitial lung disease and can be caused by mutations in NHP2 ribonucleoprotein (NHP2), a component of the telomerase complex. • We identified a novel mutation (c.70 T > A/p.Y24N) in NHP2 in a Chinese family with IPF, chronic obstructive lung disease and lung carcinoma. A functional study confirmed that this mutation can disrupt the expression and nucleocytoplasmic localization of NHP2, further decrease the expression of Dyskerin Pseudouridine Synthase 1 and Regulator of Telomere Elongation Helicase 1, and reduce the length of telomeres. • Our study expanded the mutation and clinical spectrum of NHP2 deficiency.
biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?